Abstract
The interphase of genetics and carcinogenesis has been a field of active investigation ever since the realization that mutagenicity, or more precisely the ability to alter DNA, could be the basis of cancer causation. Indeed, this realization, which ultimately led to the “carcinogens are mutagens” paradigm (Ames et al. 1973), also spawned the field of genetic toxicology. Of course, the “somatic mutation theory of cancer causation” as well as the “electrophilic theory of carcinogenesis” (Miller and Miller 1977) received confirmation by the recognition of the role in carcinogenesis of the activation of proto-oncogenes and the deactivation of suppressor genes by mutagenic mechanisms. Indeed, the relevance of these approaches and theories to human cancers was shown by the fact that the majority of carcinogens that cause cancer in humans are mutagenic and or genotoxic (Ennever et al. 1987; Shelby 1988; Bartsch and Malaveille 1989) and that the induction (initiation) of human tumors is accompanied by oncogene activation and/or Suppressor inactivation (Mariyama et al. 1989; Aaronson 1991; Hollstein et al. 1991; Reynolds et al. 1991; Sidransky et al. 1991; Weinberg 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson SA (1991) Growth factors and Cancer. Science 254:1146–1153
Ames BN, Lee FD, Durston WE (1973) An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci USA 70:782–786
Ames BN, Durston WE, Yamasaki E, Lee FD (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281–2285
Ames BN, Gold LS (1990) Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci 87:7772–7776
Andersen ME, Higginson J, Krewski D, Munro IC, Pegg AE, Rosenkranz HS, Solomon KR, Weisburger E, Williams GM, Wogan GN (1990) Safety assessment procedures for indirect food additives, an overview. Reg Toxicol Pharmacol 12:2–12
Ashby J (1985) Fundamental structural alerts to potential carcinogenicity or non-carcinogenicity. Environ Mutagen 7:919–921
Ashby J, Morrod RS (1991) Detection of human carcinogens. Nature 352:185–186
Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U. S. NCI/NTP. Mutat Res 204:17–115
Ashby J, Tennant RW (1991) Definitive relationships among chemical structure, carcinogenicityand mutagenicity for 301 chemicals tested by the U. S. NTP. Mutat Res 257:229–306
Ashby J, Tennant RW, Zeiger E, Stasiewicz S (1989) Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. Mutat Res 223:73–103
Ashby J, Vlachos DA, Tinwell H (1991a) Activity of aniline in the mouse bone marrow micronucleus assay. Mutat Res 263:115–117
Ashby J, Lefevre PA, Tinwell H, Brunborg G, Schmezer P, Pool-Zobel B, Shanu-Wilson R, Holme JA, Soderlund EJ, Gulati D, Wojciechowski JP (1991b) The non-genotoxicity to rodents of the potent rodent bladder carcinogens o-anisidine and p-cresidine. Mutat Res 250:115–133
Bartsch H, Malaveille C (1989) Prevalence of genotoxic chemicals among animal and humancarcinogens evaluated in the I ARC Monograph Series. Cell Biol Toxicol 5:115–127
Butterworth BE (1990) Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat Res 239:117–132
Chankong V, Haimes YY, Rosenkranz HS, Pet-Edwards J (1985) The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. Mutat Res 153:135–166
Cohen SM, Ellwein LB (1990) Cell proliferation in carcinogenesis. Science 249:1007–1011
Cohen SM, Ellwein LB (1991) Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51:6493–6505
Ennever FK, Rosenkranz HS (1988) The influence of the proportions of carcinogens on the cost effectiveness of short-term tests. Mutat Res 197:1–13
Ennever FK, Noonan TJ, Rosenkranz HS (1987) The predictivity of animal bioassays and short- term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis 2:73–78
Gold LS, Sawyer CB, Magaw R, Backman GM, de Veciana M, Levinson R, Hooper NK, Havender WR, Bernstein L, Peto R, Pike MC, Ames BN (1984) A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect 58:9–319
Gold LS, de Veciana M, Backman GM, Magaw R, Lopipero P, Smith M, Blumenthal M, Levinson R, Bernstein L, Ames BN (1986) Chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December, 1982. Environ Health Perspect 67:161–200
Gold LS, Slone TH, Backman GM, Magaw R, Da Costa M, Lopipero P, Blumenthal M, Ames BN (1987) Second chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December, 1984 and by the National Toxicology Program through May, 1986. Environ Health Perspect 74:237–329
Gold LS, Bernstein L, Magaw R, Slone TH (1989) Interspecies extrapolation in carcinogenesis:prediction between rats and mice. Environ Health Perspect 81:211–219
Green M (1988) Short-term tests and the myth of the non-clastogenic mutagen. Mutagenesis 3:369–371
Heddle JA, Cimino MC, Hayashi M, Romagna F, Shelby MD, Tucker JD, Vanparys PH, MacGregor JT (1991) Micronuclei as an index of cytogenetic damage: past, present and future. Environ Mol Mutagen 18:277–291
Hollstein M, McCann J, Angelsanto FT, Nichols WW (1979) Short-term tests for carcinogens and mutagens. Mutat Res 65:133–226
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 Mutations in human cancers. Science 253:49–53
IARC (1987a) Monographs on the evaluation of carcinogenic risks to humans: genetic and related effects, Suppl 6. Genetic and related effects. International Agency for Research on Cancer, Lyon
IARC (1987b) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Suppl 7. International Agency for Research on Cancer, Lyon
IARC (1988) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Suppl 6. International Agency for Research on Cancer, Lyon
IARC (1991) Mechanisms of carcinogenesis in risk identification: a consensus report of an IARC monographs working group, June 11–18, 1991. IARC Int Tech Rep 91/002. International Agency for Research on Cancer, Lyon
Klopman G, Rosenkranz HS (1991a) Quantification of the predictivity of some short-term assays for carcinogenicity in rodents. Mutation Res 253:237–240
Klopman G, Rosenkranz HS (1991b) Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity data bases. Environ Health Perspect 96:67–75
Klopman G, Frierson MR, Rosenkranz HS (1990) The structural basis of the mutagenicity of chemicals in Slmonella typhimurium: the Gene-Tox data base. Mutat Res 228:1–50
Lave LB, Ennever FK, Rosenkranz HS, Omenn GS (1988) Information value of the rodent bioassay. Nature 336:631–633
Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S (1989) Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 80:622–626
Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JA (1990) The in vivo micro- nucleus assay in mammalian bone marrow and peripheral blood: a report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 239:29–80
Miller JA, Miller EC (1977) Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Hiatt HH, Watson JD, Winsten JA (eds) Origins of human cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 605–627
National Academy of Sciences (1984) Toxicity testing: strategies to determine needs and priorities. National Academy Press, Washington DC
Reynolds SH, Anna CK, Brown KC, Wiest JS, Beattie EJ, Pero RW, Iglehart JD, Anderson MW (1991) Activated protooncogenes in human lung tumors from smokers. Proc Natl Acad Sci USA 88:1085–1089
Rosenkranz HS (1992) Strategies for the rapid detection and identification of environmental carcinogens. In: Rom WN (ed) Environmental and occupational medicine, 2nd edn, Little, Brown and Co Boston, pp 135–146
Rosenkranz HS, Ennever FK (1988) Quantifying genotoxicity and non-genotoxicity. Mutat Res 205:59–67
Rosenkranz HS, Klopman G (1989) Structural basis of the mutagenicity of phenylazoaniline dyes. Mutat Res 221:217–239
Rosenkranz HS, Klopman G (1990) Structural alerts to genotoxicity: the interaction of human and artificial intelligence. Mutagenesis 5:333–361
Rosenkranz HS, Klopman G (1991) An expert system approach to the prediction and elucidation of the structural basis of toxicological activities. In: Goldberg AM (ed) Alternative methods in toxicology, vol 8, in vitro toxicology: new technology. Mary Ann Liebert, New York, pp 145–162.
Rosenkranz HS, Klopman G (1992) 1, 4-Dioxane: Prediction of in vivo clastogenicity. Mutation Res 280:245–251
Rosenkranz HS, Ennever FK, Dimayuga M, Klopman G (1990a) Significant differences in the structural basis of the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Environ Mol Mutagen 16:149–177
Rosenkranz HS, Ennever FK, Klopman G (1990b) Relationship between carcinogenicity in rodents and the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Mutagenesis 5:559–571
Rosenkranz HS, Zhang YP, Klopman G (1991a) Implications of newly recognized relationships between mutagenicity, genotoxicity and carcinogenicity of molecules. Mutation Res. 250:25–33
Rosenkranz HS, Takihi N, Klopman G (1991b) Structure-activity based predictive toxicology: An efficient and economical method for generating non-congeneric data bases. Mutagenesis 6:391–394.
Shelby MD (1988) The genetic toxicity of human carcinogens and its implications. Mutat Res 204:3–15
Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, Vogelstein B (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706–709
Swenberg JA, Short B, Borghoff S, Strasser J, Charbonneau M (1989) The comparative pathobiology of 2-globulin nephropathy. Toxicol Appl Pharmacol 97:35–46
Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987) Prediction of chemical carcinogenicity in rodents from in vitro genotoxicity assays. Science 236:933–941
Tinwell H, Ashby J (1991) Micronucleus morphology as a means to distinguish aneugens and clastogens in the mouse bone marrow micronucleus assay. Mutagenesis 6:193–196
Warr TJ, Parry JM, Callander RD, Ashby J (1990) Methyl vinyl sulphone: a new Michael-type genotoxin. Mutat Res 245:191–199
Weinberg RA (1991) Tumor suppressor genes. Science 254:1138–1146
Westmoreland C, Gatehouse DG, (1991) Effects of aniline hydrochloride in the mouse bone marrow micronucleus test after oral administration. Carcinogenesis 12:1057–1059
Williams GM (1987) Definition of a human cancer hazard. In: Butterworth BE, Slaga TJ (eds) Nongenotoxic mechanisms in carcinogenesis, Banbury Report 25. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 367–380
Williams GM (1990) Screening procedures for evaluating the potential carcinogenicity of food packaging chemicals. Reg Toxicol Pharmacol 12:30–40
Wilson JD (1989) Assessment of low-exposure risk from carcinogenesis: implications of the Knud-son-Moolgavkar two-critical mutation theory. In: Travis CC (ed) Biologically-based methods for cancer risk assessment. Plenum Press, New york, pp 275–287
Zeiger E, Haseman JK, Shelby MD, Margolin BH, Tennant RW (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ Mol Mutagen 16:1–14
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rosenkranz, H.S., Klopman, G. (1993). Exploring Genetic and Nongenetic Relationships: The Induction of Micronuclei. In: Obe, G. (eds) Advances in Mutagenesis Research. Advances in Mutagenesis Research, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77466-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-77466-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77468-3
Online ISBN: 978-3-642-77466-9
eBook Packages: Springer Book Archive